Rubicor Medical
Disposable, hand-held, minimally invasive breast biopsy device
About Rubicor Medical
Rubicor Medical, Inc. was a privately-held medical device company founded in 1998 by interventional cardiologist Dr. James W. Vetter, who also served as Chairman and CEO. The company, based in Redwood City, California, focused on the development and distribution of technologically advanced, disposable, and minimally-invasive breast biopsy devices.
The company's product line aimed to provide alternatives to existing breast biopsy methods. Its devices included the Rubicor Breast Biopsy Device, intended for diagnostic sampling of breast tissue. The device received 510(k) clearance from the U.S. Food and Drug Administration (FDA), permitting it to be marketed as it was determined to be substantially equivalent to legally marketed predicate devices. Rubicor's portfolio included products like the Ovation™, designed to capture complete breast tissue abnormalities with a minimally invasive procedure, and the Rubicor Bravo™, a self-contained, disposable, hand-held tool for coring, storing, and transporting tissue. Other devices marketed by the company included the Flash™, Phantom™, and Halo™, each designed for specific aspects of breast biopsy and tissue removal, such as single-insertion, multi-sampling core biopsy and soft-tissue excision.
Rubicor Medical secured significant funding to support its growth and operations. In August 2006, the company completed a $30 million Series C financing round led by Safeguard Scientifics, which invested $20 million. The following year, it entered into a $10 million venture debt credit facility agreement with Comerica Bank and Oxford Finance Corporation to support working capital and other corporate growth initiatives.
Source: Dealroom company dataNews
Open roles
Rubicor Medical in the Redwood City ecosystem
The Rubicor Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Safeguard Scientifics
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Rubicor Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rubicor Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.